En
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer/E-commerce
Digital Media / Internet
Industrial Technology
Life Sciences and Healthcare
Software / TMT
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Hanza Holding AB
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
In Media
M&A Know-how
Macro and markets
Market Snapshots
24 Feb 2023
Research Update SBB i Norden Q4 2022: Better earnings outweigh lower NAV
Equity Research
SBB i Norden
23 Feb 2023
First Impression SBB i Norden, Q4 2022: Better earnings capacity than expected
Equity Research
SBB i Norden
10 Feb 2023
Preview SBB, Q4 2022: Better valued after transactions
Equity Research
SBB i Norden
05 Dec 2022
Research Update SBB i Norden: Large deal with Brookfield strengthens finances
Equity Research
SBB i Norden
28 Oct 2022
Research Update SBB i Norden, Q3 2022: On track to handle the financial challenges
Equity Research
SBB i Norden
27 Oct 2022
First Impression SBB i Norden, Q3 2022: Greater depreciation than expected
Equity Research
SBB i Norden
13 Oct 2022
Preview SBB, Q3 2022: Same earning capacity with smaller property portfolio
Equity Research
SBB i Norden
15 Jul 2022
Research Update SBB i Norden, Q2 2022: Currency and valuation effects lowered results
Equity Research
SBB i Norden
14 Jul 2022
First Impression SBB i Norden, Q2 2022: Net operating income as expected, but property impairments
Equity Research
SBB i Norden
29 Jun 2022
Preview SBB i Norden: Divesting and consolidating for higher rating
Equity Research
SBB i Norden
07 Jun 2022
Mrkt BUZZ SBB i Norden: New Euro loan financing shows capacity
Equity Research
SBB i Norden
28 Apr 2022
Analysis Update SBB i Norden, Q1 2022: Better start in the beginning of the year than expected
Equity Research
SBB i Norden
27 Apr 2022
First Impression SBB i Norden Q1 2022: Better-than-anticipated results - JV and capital gains contributed
Equity Research
SBB i Norden
13 Apr 2022
Preview SBB i Norden: Low valued stock relative to the real estate sector
Equity Research
SBB i Norden
25 Feb 2022
Research Update SBB i Norden, Q4 2021: Continued capital gains in the properties
Equity Research
SBB i Norden
23 Feb 2022
First impression, SBB i Norden Q4/2021: SEK 2.2 billion in profit from associated companies and higher NRV
Equity Research
SBB i Norden
10 Feb 2022
Preview SBB i Norden: Value added gains on the properties
Equity Research
SBB i Norden
07 Jan 2022
Mrkt BUZZ SBB i Norden: Target price raised to SEK 70 per share after new forecast
Equity Research
SBB i Norden
08 Nov 2021
Analysis SBB i Norden, Q3 2021: Increased property values and projects boost earnings
Equity Research
SBB i Norden
04 Nov 2021
First Impression SBB i Norden, kv3 2021: Property values increases three times higher than forecast
Equity Research
SBB i Norden